Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Enliven Therapeutics (ELVN) Tax Provisions (2024)

Enliven Therapeutics has reported Tax Provisions over the past 1 years, most recently at $232000.0 for Q2 2024.

  • Quarterly results put Tax Provisions at $232000.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through Jun 2025 was $232000.0 (changed N/A YoY), and the annual figure for FY2024 was $232000.0, changed.
  • Tax Provisions reached $232000.0 in Q2 2024 per ELVN's latest filing.
  • Across five years, Tax Provisions topped out at $232000.0 in Q2 2024 and bottomed at $232000.0 in Q2 2024.